Immuneel
Developer of a cell therapy intended to provide cell and gene therapies for cancer treatment. The company develops CAR-T cell therapies extracted from patients' blood cells by using genetic engineerin...
Valuation
$67.9M
Market implied
Share Price
N/A
Total Raised
$38M
Last Round
N/A